Form 4: BioCorRx Inc. Executive Acquires Additional Shares as Part of Service Agreement

Louis C. Lucido, President of BioCorRx Inc., acquired additional shares of common stock in January and February 2024 as part of his Executive Service Agreement.

Summary

• Louis C. Lucido, President of BioCorRx Inc., has reported changes in his beneficial ownership of the company's common stock.
• On January 31, 2024, Mr. Lucido acquired 18,269 shares at $0.00 per share.
• On February 29, 2024, he acquired 16,892 shares at $0.00 per share.
• These acquisitions were made pursuant to an Executive Service Agreement where Mr. Lucido receives shares equivalent to $16,666.66 per month based on the average closing price of the company's stock for the three trading days immediately preceding the last day of each month.
• Following these transactions, Mr. Lucido beneficially owns 510,094 shares of BioCorRx Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports transactions related to executive compensation. The fact that the executive is receiving shares could be seen as a positive, but it's also part of a pre-existing agreement.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but it implies that Mr. Lucido will continue to receive shares monthly under the terms of his Executive Service Agreement.

Industry Context

Executive compensation in the form of stock options or grants is a common practice in the pharmaceutical and biotechnology industries to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation is a common practice across various industries, particularly in growth-oriented sectors like biotechnology.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options and grants as part of their executive compensation packages.
• The specific amount and terms of these agreements vary widely based on company size, performance, and industry benchmarks.

Stakeholder Impact

• Shareholders may view the executive's increased stake in the company positively, as it aligns his interests with theirs.
• Employees may see this as a sign of stability and confidence in the company's leadership.

Key Dates

Keywords

BioCorRx Inc., Louis C. Lucido, Beneficial Ownership, Executive Service Agreement, Common Stock, Form 4, BICX